Christina Tsigalou

Prof. Dr. Christina Tsigalou

Department of medicine Democritus University of Thrace, Alexandroúpoli, Anatolikí Makedonía kai Thráki, Greece
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
NVNatalia Vaou
Natalia Vaou
ESElisavet Stavropoulou
Elisavet Stavropoulou
CVChrysoula (Chrysa) Voidarou
Chrysoula (Chrysa) Voidarou
Christina TsigalouChristina Tsigalou
Christina Tsigalou
EUGENIA BEZIRTZOGLOUEUGENIA BEZIRTZOGLOU
EUGENIA BEZIRTZOGLOU
The increasing incidence of drug- resistant pathogens raises an urgent need to identify and isolate new bioactive compounds from medicinal plants using standardized modern analytical procedures. Medicinal plant-derived compounds could provide novel straightforward approaches against pathogenic bacteria. This review explores the antimicrobial activity of plant-derived components, their possible mechanisms of action, as well as their chemical potential. The focus is put on the current challenges and future perspectives surrounding medicinal plants antimicrobial activity. There are some inherent challenges regarding medicinal plant extracts and their antimicrobial efficacy. Appropriate and optimized extraction methodology plant species dependent leads to upgraded and selective extracted compounds. Antimicrobial susceptibility tests for the determination of the antimicrobial activity of plant extracts may show variations in obtained results. Moreover, there are several difficulties and problems that need to be overcome for the development of new antimicrobials from plant extracts, while efforts have been made to enhance the antimicrobial activity of chemical compounds. Research on the mechanisms of action, interplay with other substances, and the pharmacokinetic and/or pharmacodynamic profile of the medicinal plant extracts should be given high priority to characterize them as potential antimicrobial agents.

2 November 2020 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
PSPanagiotis Skendros
Panagiotis Skendros
AMAlexandros Mitsios
Alexandros Mitsios
ACAkrivi Chrysanthopoulou
Akrivi Chrysanthopoulou
DMDimitrios C. Mastellos
Dimitrios C. Mastellos
SMSimeon Metallidis
Simeon Metallidis
KRKonstantinos Ritis
Konstantinos Ritis
Emerging data indicate that complement and neutrophils contribute to the maladaptive immune response that fuels hyperinflammation and thrombotic microangiopathy, thereby increasing coronavirus 2019 (COVID-19) mortality. Here, we investigated how complement interacts with the platelet/neutrophil extracellular traps (NETs)/thrombin axis, using COVID-19 specimens, cell-based inhibition studies, and NET/human aortic endothelial cell (HAEC) cocultures. Increased plasma levels of NETs, tissue factor (TF) activity, and sC5b-9 were detected in patients. Neutrophils of patients yielded high TF expression and released NETs carrying active TF. Treatment of control neutrophils with COVID-19 platelet-rich plasma generated TF-bearing NETs that induced thrombotic activity of HAECs. Thrombin or NETosis inhibition or C5aR1 blockade attenuated platelet-mediated NET-driven thrombogenicity. COVID-19 serum induced complement activation in vitro, consistent with high complement activity in clinical samples. Complement C3 inhibition with compstatin Cp40 disrupted TF expression in neutrophils. In conclusion, we provide a mechanistic basis for a pivotal role of complement and NETs in COVID-19 immunothrombosis. This study supports strategies against severe acute respiratory syndrome coronavirus 2 that exploit complement or NETosis inhibition.

28 July 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
NVNatalia Vaou
Natalia Vaou
ESElisavet Stavropoulou
Elisavet Stavropoulou
CVChrysoula (Chrysa) Voidarou
Chrysoula (Chrysa) Voidarou
ZTZacharias Tsakris
Zacharias Tsakris
GRGeorgios Rozos
Georgios Rozos
EUGENIA BEZIRTZOGLOUEUGENIA BEZIRTZOGLOU
EUGENIA BEZIRTZOGLOU
It is accepted that the medicinal use of complex mixtures of plant-derived bioactive compounds is more effective than purified bioactive compounds due to beneficial combination interactions. However, synergy and antagonism are very difficult to study in a meticulous fashion since most established methods were designed to reduce the complexity of mixtures and identify single bioactive compounds. This study represents a critical review of the current scientific literature on the combined effects of plant-derived extracts/bioactive compounds. A particular emphasis is provided on the identification of antimicrobial synergistic or antagonistic combinations using recent metabolomics methods and elucidation of approaches identifying potential mechanisms that underlie their interactions. Proven examples of synergistic/antagonistic antimicrobial activity of bioactive compounds are also discussed. The focus is also put on the current challenges, difficulties, and problems that need to be overcome and future perspectives surrounding combination effects. The utilization of bioactive compounds from medicinal plant extracts as appropriate antimicrobials is important and needs to be facilitated by means of new metabolomics technologies to discover the most effective combinations among them. Understanding the nature of the interactions between medicinal plant-derived bioactive compounds will result in the development of new combination antimicrobial therapies.

29 May 2020 in Current Obesity Reports
Verified
Journal Article
Closed access
PDF file
Natalia G. VallianouNatalia G. Vallianou
Natalia G. Vallianou
TSTheodora Stratigou
Theodora Stratigou
GCGerasimos Socrates Christodoulatos
Gerasimos Socrates Christodoulatos
Christina TsigalouChristina Tsigalou
Christina Tsigalou
MDMaria Dalamaga
Maria Dalamaga

8 July 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
Christina TsigalouChristina Tsigalou
Christina Tsigalou
Theocharis G KonstantinidisTheocharis G Konstantinidis
Theocharis G Konstantinidis
APAfroditi Paraschaki
Afroditi Paraschaki
ESElisavet Stavropoulou
Elisavet Stavropoulou
CVChrysoula (Chrysa) Voidarou
Chrysoula (Chrysa) Voidarou
EUGENIA BEZIRTZOGLOUEUGENIA BEZIRTZOGLOU
EUGENIA BEZIRTZOGLOU
Since ancient times, the quality of nourishment is a milestone for the maintenance of health and as it is stated ‘prevention is better than cure’, amongst the so-called ‘healthy’ diets Mediterranean diet (MD) claims the lion’s share. It stands in good stead because of a variety of valuable macro- and micronutrients. So, adherence to a MD is associated with the reduction of inflammation and non-communicable (NCD) OR chronic diseases. Numerous studies try to scrutinize the role of MD components as regards reducing inflammation, lowering rate, and mortality for disorders and illnesses, and preventing NCD. MD regime of the inhabitants of the Mediterranean basin includes a variety of ethnic nutritional habits and regulates an array of effects and epigenetic changes that affect human wellbeing. The research is still ongoing and endeavors to elucidate every aspect of this issue. This review focuses on the impact of MD on inflammation highlights positive results regarding NCD and indicates the need for more high-quality experiments and trials in order to overcome any discrepancies.

16 November 2020 in Biomedicines
Verified
Journal Article
Open access
PDF file
Theocharis G KonstantinidisTheocharis G Konstantinidis
Theocharis G Konstantinidis
Christina TsigalouChristina Tsigalou
Christina Tsigalou
AKAlexandros Karvelas
Alexandros Karvelas
ESElisavet Stavropoulou
Elisavet Stavropoulou
CVChrysoula (Chrysa) Voidarou
Chrysoula (Chrysa) Voidarou
EUGENIA BEZIRTZOGLOUEUGENIA BEZIRTZOGLOU
EUGENIA BEZIRTZOGLOU
The human gastrointestinal tract carries a large number of microorganisms associated with complex metabolic processes and interactions. Although antibiotic treatment is crucial for combating infections, its negative effects on the intestinal microbiota and host immunity have been shown to be of the utmost importance. Multiple studies have recognized the adverse consequences of antibiotic use upon the gut microbiome in adults and neonates, causing dysbiosis of the microbiota. Repeated antibiotic treatments in clinical care or low-dosage intake from food could be contributing factors in this issue. Researchers in both human and animal studies have strived to explain this multifaceted relationship. The present review intends to elucidate the axis of the gastrointestinal microbiota and antibiotics resistance and to highlight the main aspects of the issue.